Generic Pharmaceutical

Interact & exchange stock tips & market info »
Related News »
Makov is the former president and chief executive of Teva Pharmaceutical Industries Ltd., the world's largest generic drugs maker. He is chairman of several companies spanning businesses from diagnostic devices to life sciences investment.
May 29, 2012 at 15:30 | Source: Marketwatch
Mr. Makov is the former President and CEO of Teva Pharmaceutical Industries Ltd (2002-2007). He is among Israel's most respected corporate leaders, and is widely credited with Teva's emergence as a global company and a world leader in generic pharmaceuticals.
May 29, 2012 at 13:36 | Source: 4-traders (press release)
Makov is the former president and chief executive of Teva Pharmaceutical Industries Ltd., the world's largest generic drugs maker. He is chairman of several companies spanning businesses from diagnostic devices to life sciences investment. The appointment ...
May 29, 2012 at 13:36 | Source: 4-traders (press release)
Lipitor was the biggest-selling pharmaceutical in the world before the patents supporting the drug expired in 2011. Under terms of a deal with Pfizer Inc., Watson Pharmaceuticals Inc. made the authorized U.S. generic version of Lipitor and India's Ranbaxy ...
May 29, 2012 at 18:51 | Source: CNBC
But Teva Pharmaceutical Industries ($TEVA ... Making copycat Lipitor would have required a big chunk of its API and oral-dosage capacity. Plus, the generic Lipitor market is more crowded than Teva had expected; 8 companies are planning new ...
May 29, 2012 at 15:23 | Source: FiercePharma
Atorvastatin Calcium is the generic version of Pfizer's Lipitor® Tablets ... according to IMS Health. Mylan is a global pharmaceutical company committed to setting new standards in health care. Working together around the world to provide ...
May 29, 2012 at 17:10 | Source: Yahoo Finance
Taro Pharmaceutical almost doubled its sales and net profit. Sun Pharma also announced the appointment of Israel Makov as the new chairman. Makov is the former president and chief executive of the world’s largest generic drug maker Teva Pharmaceutical ...
May 29, 2012 at 16:35 | Source: Livemint.com
May 29, 2012 (Globes - McClatchy-Tribune Information Services via COMTEX News Network) -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) has decided not to market Atorvastatin, the generic version of Pfizer Inc. (NYSE: PFE) cholesterol ...
May 29, 2012 at 16:49 | Source: comcast.net
Crestor Benefit Program now covers the difference in cost between generic & brand HALIFAX, May 29, 2012 /CNW/ - Canadian pharmaceutical manufacturer, AstraZeneca, modifies the recently launched Crestor Prescription Benefit cards to cover the difference in ...
May 29, 2012 at 11:48 | Source: Phramalive.com
Testim is facing additional competition in the form of Endo Pharmaceutical’s (NASDAQ:ENDP) Fortesta and Eli Lilly’s (NYSE:LLY) Axiron. The testosterone gel market will become even more competitive from 2015 when generic versions of AndroGel ...
May 29, 2012 at 18:08 | Source: Daily Markets